When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNJ - J&J files application in Japan for subcutaneous formulation of Darzalex
Johnson & Johnson
Johnson & Johnson (NYSE:JNJ) unit Janssen Pharmaceutical K.K. has filed a marketing application in Japan for a subcutaneous formulation of multiple myeloma med Darzalex (daratumumab).
More news on: Johnson & Johnson, Halozyme Therapeutics, Inc., Healthcare stocks news, Stocks on the move,